Xalnesiran
Xalnesiran (RO7445482) is a small interfering RNA molecule that targets a conserved region of the
hepatitis B virus (HBV) genome. Xalnesiran can be used for the research of chronic hepatitis B infection.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2538784-48-2
- Fòrmula: C664H871F17N231O415P57S6
- Peso molecular:21009.15
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
In Vitro
Chemical Information
-
No. CAS 2538784-48-2
-
Peso molecular 21009.15
-
Fòrmula C664H871F17N231O415P57S6
-
SMILES
[Xalnesiran]
-
Synonyms
RO7445482
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Hui RW, et al. Emerging therapies for HBsAg seroclearance: spotlight on novel combination strategies. Hepatol Int. 2025;19(4):704-719. [Content Brief]
[2]. Tang Q, et al. Xalnesiran with or without an immunomodulator in chronic hepatitis B: still a challenge in functional cure. Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):348-350. [Content Brief]
[3]. Hou J, et al. Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B. N Engl J Med. 2024 Dec 5;391(22):2098-2109. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)